Skip to main content

Table 2 Details of A. baumannii isolates, by sequence type

From: Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China

    

Non-susceptible to (%):

Resistant determinants

ST

No.

Allelic profile

Time course

IPM

TZP

TCC

CAZ

AMK

LVX

MNO

191

32

1-3-3-2-2-94-3

Aug. 2009

Feb. 2011–May. 2012

100

100

100

100

38

100

23

OXA-51, OXA-23, AMPC

195

31

1-3-3-2-2-96-3

Mar. 2013–Nov. 2014

100

100

100

100

97

100

100

OXA-51, OXA-23, AMPC

208

15

1-3-3-2-2-97-3

Jul. 2010–Oct. 2014

100

100

100

93

100

100

100

OXA-51, OXA-23, AMPC

218

2

1-3-3-2-2-102-3

Jul. 2011–Aug. 2011

100

100

100

100

100

100

0

OXA-51, OXA-23, AmpC

368

6

1-3-3-2-2-140-3

Jun. 2009–Sep. 2014

100

100

100

100

67

67

33

OXA-51, OXA-23, AmpC

369

1

1-3-3-2-2-106-3

Jun. 2013

100

100

100

100

0

100

-

OXA-51, OXA-23, AmpC

373

2

1-12-12-11-4-103-3

Mar. 2011, Apr. 2011

100

100

100

100

0

100

0

OXA-51, AmpC

383

2

1-12-56-1-4-149-45

Aug. 2011

100

100

100

100

100

100

100

OXA-51, AmpC

429

2

1-34-56-1-4-144-45

Jul. 2011, Sep. 2011

100

100

100

100

50

50

100

OXA-51, OXA-23, AmpC

469

6

1-12-3-2-2-103-3

Dec. 2012-Nov. 2013

100

100

100

100

100

100

100

OXA-51, OXA-23, AmpC

1302n

1

2-52-80-6-23-140-4

Jul. 2014

100

100

100

0

0

0

0

OXA-51, OXA-40, AmpC

1309n

1

27-155n-99-55-25 -270n-60

Aug. 2011

100

100

100

100

100

100

100

OXA-51, AmpC

Total

101

-

Jun. 2009–Nov. 2014

100

100

100

98

80

96

68

-

  1. nNovel; IPM imipenem, TZP piperacillin/tazobactam, TCC ticarcillin/clavulanic acid, CAZ ceftazidime, AMK amikacin, LVX levofloxacin, MNO minocycline